Max Chan

Max Chan is currently a Member-Supervisory Board at Wisepal Technologies, Inc., Harvest Investments Ltd., Himax Imaging Ltd., Himax Media Solutions, Inc., Himax Taiwan, Inc., Himax Semiconductor Ltd., Eden Biologics, Inc., and Foresee Pharmaceuticals Co., Ltd. He previously worked as a Manager-Intel Capital Treasury at Intel Corp., Manager-Overseas Direct Investment Department at CDIB Capital Group, Chief Financial Officer at Himax Technologies, Inc., CFO, Head-Finance & Administration at TaiGen Biotechnology Co., Ltd., Senior Associate at Credit Suisse First Boston Asia International (Cayman) Ltd., and Deputy General Manager & Head-Finance at OBI Pharma, Inc. Mr. Chan received a graduate degree from the University of Illinois and undergraduate and MBA degrees from National Taiwan University.